What Idaho's 1115 Behavioral Health Waiver Means for Facilities

As of September 2026, Idaho's Section 1115 Behavioral Health Transformation waiver authorizes Idaho Medicaid to pay for residential treatment and withdrawal management stays for adults ages 21 to 64 in facilities that would otherwise be excluded under the federal "institutions for mental diseases" (IMD) rule. That authority, added by a March 2024 amendment and currently extended through March 31, 2027, turns a population that operators previously had to serve on self-pay, grants, or short crisis-only coverage into a Medicaid-billable payer segment, provided the facility holds national accreditation, meets Idaho's level-of-care and length-of-stay rules, and is enrolled in the Magellan of Idaho (IBHP) network. For anyone modeling a new Idaho facility or evaluating an existing one, this is the single biggest change to the revenue side of the pro forma in years.

What Is Idaho's 1115 Behavioral Health Transformation Waiver?

Idaho's Behavioral Health Transformation demonstration is a Section 1115 Medicaid waiver, first approved by the Centers for Medicare & Medicaid Services (CMS) on April 17, 2020. Section 1115 lets a state ask CMS for permission to pay federal Medicaid dollars for services or settings the underlying Medicaid statute would otherwise exclude. In Idaho's case, the exclusion at issue is the IMD exclusion: the decades-old federal rule that blocks Medicaid from paying for care in a freestanding psychiatric or substance use facility with more than 16 beds. The original 2020 approval opened the door for adults 21 to 64 receiving acute psychiatric care in IMDs. It did not, on its own, cover residential substance use disorder (SUD) treatment or withdrawal management. For the full picture of how this waiver fits alongside Idaho's licensing and accreditation framework, see our Idaho behavioral health licensing guide.

What Changed for Residential and Withdrawal Management Facilities in 2024?

CMS approved an amendment to the demonstration on March 29, 2024 (see the approval letter) that extended federal financial participation (FFP) to adults 21 to 64 "primarily receiving treatment and withdrawal management services" in IMD-classified residential and inpatient settings. That is the provision operators actually feel: it is what makes a residential SUD program or a freestanding withdrawal management unit fundable through Idaho Medicaid rather than self-pay or grant funding alone. For the licensure and accreditation mechanics behind each setting, see our guides to residential treatment center licensing in Idaho and Idaho withdrawal management and detox licensing.

The amendment came with a budget-neutrality mechanism that every operator building a pro forma needs to understand, because it caps how long a single stay can be billed:

• 30-day target. Idaho must maintain a statewide average length of stay (ALOS) of 30 days across residential and inpatient IMD settings.
• 60-day ceiling if the state hits the target. When Idaho demonstrates the 30-day statewide ALOS, individual stays can be billed up to 60 days.
• 45-day ceiling if it doesn't. If the state falls outside that benchmark, the billable ceiling on individual stays drops to 45 days until compliance is re-established.

That statewide, aggregate metric is outside any single facility's control, but it is directly influenced by how every IBHP-network facility manages length of stay and discharge planning. A program that habitually pushes stays past what clinical necessity supports doesn't just risk its own utilization review findings. It drags on the number every facility in the state is measured against.

Is the Waiver Still in Effect in 2026?

Yes. As of this writing, CMS's demonstration record for Idaho shows the program authorized through March 31, 2027, with Idaho's formal extension application (filed March 12, 2025) still under review and CMS granting temporary extensions to bridge the gap, most recently on August 28, 2026. In practice, that means the revenue authority described in this post is active today, but it is not permanent law: it is a demonstration that Idaho has to keep re-justifying to CMS on a defined evaluation cycle, including annual monitoring reports and an interim evaluation. Operators underwriting a facility on this payer stream should build refinancing and extension risk into their assumptions the same way they would with any grant-funded or demonstration-dependent revenue line, and should revisit the current expiration date on the Idaho Department of Health & Welfare's waiver page before finalizing a five-year model.

How Does This Change a Facility's Payer Mix and Revenue Model?

Before the March 2024 amendment, an Idaho residential SUD or withdrawal management program serving adults 21 to 64 in an IMD-classified facility had essentially three revenue options: private pay, philanthropic or state grant funding, or narrow crisis-stabilization carve-outs that didn't cover a full residential episode. Idaho Medicaid was not one of them for this population and setting. The 2024 amendment adds Idaho Medicaid, routed through the Magellan of Idaho (IBHP) network, as a fourth, standing revenue source, without removing the other three.

For a founder building a first Idaho facility, that changes the census assumptions that drive the whole pro forma: a payer mix that used to be self-pay-heavy, with a hard ceiling on how many beds could realistically fill given local ability to pay, can now model a Medicaid-eligible segment of the 21 to 64 adult population as a genuine demand source. For an existing operator, it changes the calculus on whether beds that have been sitting idle waiting for private-pay or grant-funded clients are worth reactivating, and whether it's worth adding IMD-eligible capacity at all.

It doesn't change everything. The 30/45/60-day length-of-stay mechanics mean this isn't a payer that rewards long-stay, low-acuity residential models. It rewards programs built around a clearly staged, clinically justified length of stay with a real discharge plan into a lower level of care. Facilities that already run PHP/IOP step-down capacity, or that have a warm referral relationship with one, are better positioned to use the new funding than a residential-only operator with no step-down pathway.

What Do You Need in Place to Actually Bill This Revenue?

The waiver creates the funding authority; it doesn't hand it to a facility automatically. Idaho's own rules tie eligibility to a specific set of operational prerequisites:

• National accreditation. Under IDAPA 16.07.17.395, a residential treatment program must be nationally accredited by the Joint Commission, the Council on Accreditation (COA), or CARF. There is no path to billing this waiver's residential or withdrawal management authority without one of those three.
• ASAM Level of Care certification. The same rule section requires the program to maintain ASAM Level of Care certification matching the services actually delivered. Accreditation alone isn't sufficient.
• Magellan of Idaho (IBHP) network enrollment. Idaho Medicaid behavioral health claims for this population route through Magellan of Idaho, which took over the IBHP contract from Optum on July 1, 2024. Credentialing and contracting with Magellan is a separate, sequential step from accreditation, not something that happens automatically once a facility is accredited. Our Magellan of Idaho enrollment guide walks through that process end to end.
• Utilization review and length-of-stay documentation. Because the state is tracking a statewide 30-day ALOS benchmark, expect UR scrutiny on any stay approaching the 45- or 60-day ceiling, and build documentation habits now rather than after the first denial.
• Co-occurring capability. CMS's provider requirements for this demonstration call for facilities to screen for, and demonstrate capacity to address, co-occurring physical and behavioral health conditions, not just the primary SUD or mental health diagnosis.

Every prerequisite on that list is also a service line: accreditation survey readiness sits with our licensing and accreditation consulting, and Magellan credentialing and rate negotiation sit with our payer contracting team. Most Idaho launches need both running at the same time, not sequentially.

How Should You Model This in a Facility Pro Forma?

Because Idaho Medicaid rates and unit-level reimbursement figures for this benefit are negotiated through the Magellan of Idaho contract rather than published in the federal waiver documents, don't build a pro forma on an assumed per-diem rate pulled from a national average. Build it on the structure the waiver actually imposes:

1. Model census by payer segment, not blended average. Separate self-pay/grant-funded census from the newly Medicaid-eligible 21 to 64 IMD segment. They have different acquisition costs, different average lengths of stay, and different downstream step-down needs.
2. Stress-test against the 45-day ceiling, not the 60-day ceiling. Underwriting to the best-case 60-day scenario assumes the state hits its statewide 30-day ALOS target every measurement period. A conservative model uses 45 days as the planning assumption and treats 60 as upside.
3. Price in the accreditation and IBHP enrollment timeline as a delay to revenue start, not a rounding error. Accreditation surveys, ASAM certification, and Magellan credentialing each run on their own timelines and rarely compress into a single quarter.
4. Build a step-down pathway into the model, even if you don't operate one directly. A documented referral relationship into PHP/IOP materially improves discharge planning and utilization review outcomes for a residential or withdrawal management program billing under this authority.
5. Track the extension risk as a line item, not a footnote. A demonstration authorized through March 2027, with extensions granted incrementally, is a different underwriting proposition than a permanent state-plan benefit.

Readiness Checklist: Billing Idaho's 1115 Waiver Revenue Stream

• Accreditation and ASAM certification secured or scheduled before the launch timeline assumes Medicaid revenue on day one.
• Magellan of Idaho credentialing initiated in parallel with accreditation, not after it's complete.
• Discharge and step-down pathway documented, ideally with a named referral partner for the next level of care.
• UR and length-of-stay documentation workflow built, with clinical staff ownership of medical-necessity documentation for stays approaching 30, 45, and 60 days.
• Extension risk noted in the financial model, with the current demonstration expiration date cited and revisited annually.

Frequently Asked Questions

What is Idaho's 1115 Behavioral Health Transformation waiver?

It's a Section 1115 Medicaid demonstration, first approved by CMS in April 2020 and amended in March 2024, that lets Idaho Medicaid pay federal matching funds for behavioral health services in IMD-classified facilities that would otherwise be excluded from Medicaid coverage under federal law.

Does Idaho Medicaid pay for residential treatment or detox now?

For adults ages 21 to 64 in a nationally accredited, IMD-classified facility enrolled in the Magellan of Idaho (IBHP) network, yes. As of the March 2024 amendment, residential SUD treatment and withdrawal management are both billable under this waiver authority, subject to length-of-stay limits.

How long can a facility bill Medicaid for a single IMD stay in Idaho?

Up to 60 days per stay if Idaho is meeting its statewide 30-day average-length-of-stay benchmark, or up to 45 days if it is not. The benchmark is measured statewide, not per facility, but individual facilities' length-of-stay practices affect it.

Is the waiver still active in 2026?

Yes. As of September 2026, the demonstration is authorized through March 31, 2027, with Idaho's extension application still under CMS review and temporary extensions (most recently approved August 28, 2026) keeping the program running in the meantime.

What accreditation do I need to bill under this waiver?

National accreditation from the Joint Commission, CARF, or COA, plus ASAM Level of Care certification matching the services delivered, per IDAPA 16.07.17.395.

Do I bill Idaho Medicaid directly, or through Magellan?

Through Magellan of Idaho. Magellan holds the IBHP contract (it replaced Optum on July 1, 2024) and administers behavioral health claims and network credentialing for this population.

How Saint Health Group Helps You Capture This Revenue Stream

Reading the waiver correctly is the easy part. Turning it into billable revenue means sequencing accreditation, ASAM certification, and Magellan of Idaho credentialing so they land in the right order instead of stalling each other, and building the utilization-review and documentation infrastructure a length-of-stay-capped Medicaid benefit demands before your first survey or your first audit, not after. Saint Health Group doesn't just tell you what the waiver allows; as your single accountable partner, we write the policies and procedures, implement them on-site, train your clinical and UR staff, build the documentation infrastructure a 30/45/60-day benefit requires, run a full readiness survey before the real one, and handle the payer contracting and credentialing conversations with Magellan directly. Whether the gap in your plan is licensing and accreditation, revenue cycle and payer contracting, or the operational infrastructure to support all three at once, we run it end to end. Talk to Saint Health Group about launching or expanding an Idaho facility, or contact our team to start with a readiness assessment.